Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C063002 |
2,3-dimethoxy-1,4-naphthoquinone |
2,3-dimethoxy-1,4-naphthoquinone results in increased expression of SPAG5 mRNA | increases expression | 19031421
|
C010914 |
2,4-diaminotoluene |
2,4-diaminotoluene results in increased expression of SPAG5 mRNA | increases expression | 20713471
|
D016604 |
Aflatoxin B1 |
Aflatoxin B1 affects the expression of SPAG5 protein | affects expression | 20106945
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of SPAG5 mRNA | affects expression | 16483693
|
D001374 |
Azacitidine |
[Azacitidine co-treated with Thalidomide] affects the expression of SPAG5 mRNA | affects cotreatment|affects expression | 18720364
|
D019324 |
beta-Naphthoflavone |
[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of SPAG5 mRNA | affects cotreatment|increases expression | 18164116
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of SPAG5 mRNA | decreases expression | 20064835
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in increased expression of SPAG5 mRNA | increases expression | 20713471
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of SPAG5 mRNA | decreases expression | 20382639
|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of SPAG5 mRNA | decreases expression | 20106945
|
D004052 |
Diethylnitrosamine |
[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of SPAG5 mRNA | affects cotreatment|increases expression | 18164116
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol affects the expression of SPAG5 mRNA | affects expression | 17555576
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in increased expression of SPAG5 mRNA | increases expression | 17942748
|
D004997 |
Ethinyl Estradiol |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SPAG5 mRNA | affects cotreatment|increases expression | 17942748
|
D005419 |
Flavonoids |
Flavonoids results in decreased expression of SPAG5 mRNA | decreases expression | 18035473
|
D005472 |
Fluorouracil |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of SPAG5 mRNA] | affects reaction|decreases expression | 15016801
|
D019833 |
Genistein |
Genistein affects the expression of SPAG5 mRNA | affects expression | 18847459
|
D008748 |
Methylcholanthrene |
Methylcholanthrene results in increased expression of SPAG5 mRNA | increases expression | 20713471
|
D009532 |
Nickel |
Nickel results in increased expression of SPAG5 mRNA | increases expression | 19031421
|
D010126 |
Ozone |
Ozone results in increased expression of SPAG5 mRNA | increases expression | 12763052
|
D010126 |
Ozone |
TTPA protein affects the reaction [Ozone results in increased expression of SPAG5 mRNA] | affects reaction|increases expression | 19555225
|
D010634 |
Phenobarbital |
Phenobarbital affects the expression of SPAG5 mRNA | affects expression | 19136022
|
C006253 |
pirinixic acid |
pirinixic acid affects the expression of SPAG5 mRNA | affects expression | 19136022
|
C006253 |
pirinixic acid |
pirinixic acid results in increased expression of SPAG5 mRNA | increases expression | 17950772
|
C006253 |
pirinixic acid |
PPARA protein promotes the reaction [pirinixic acid results in increased expression of SPAG5 mRNA] | increases expression|increases reaction | 17950772
|
C017947 |
sodium arsenite |
sodium arsenite results in decreased expression of SPAG5 mRNA | decreases expression | 17998272
|
D013629 |
Tamoxifen |
Tamoxifen affects the expression of SPAG5 mRNA | affects expression | 17555576
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SPAG5 mRNA | affects cotreatment|increases expression | 17942748
|
D013750 |
Tetrachloroethylene |
Tetrachloroethylene results in increased expression of SPAG5 mRNA | increases expression | 19031421
|
D013755 |
Tetradecanoylphorbol Acetate |
Tetradecanoylphorbol Acetate results in increased expression of SPAG5 mRNA | increases expression | 19031421
|
D013792 |
Thalidomide |
[Azacitidine co-treated with Thalidomide] affects the expression of SPAG5 mRNA | affects cotreatment|affects expression | 18720364
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
4.35 | 14745880 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Phenobarbital |
13.23 | 6195326 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
13.23 | 14514962 11752688 15322242 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Thalidomide |
13.23 | 8333272 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.37 | 18287403 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
3.75 | 17505938 |
MESH:D055371 |
Acute Lung Injury |
|
Nickel |
8.65 | 16166738 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
8.65 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
9.77 | 20127859 20464547 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
9.77 | 14692618 |
MESH:D000230 |
Adenocarcinoma |
|
Fluorouracil |
9.77 | 17638652 |
MESH:D000230 |
Adenocarcinoma |
|
Genistein |
9.77 | 11473722 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
15.12 | 6695378 |
MESH:D000236 |
Adenoma |
|
beta-Naphthoflavone |
15.12 | 19389873 |
MESH:D000236 |
Adenoma |
|
Diethylnitrosamine |
15.12 | 6695378 10737359 |
MESH:D000236 |
Adenoma |
|
Methylcholanthrene |
15.12 | 10545420 6695378 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Diethylnitrosamine |
23.27 | 19052882 17162532 16434500 17620307 18056438 19061943 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Phenobarbital |
23.27 | 17620307 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
23.27 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
23.27 | 16835633 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.51 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
4.71 | 17306315 16712894 |
MESH:D000544 |
Alzheimer Disease |
|
Ozone |
2.40 | 15513908 |
MESH:D000690 |
Amyotrophic Lateral Sclerosis |
|
Thalidomide |
4.24 | 16510725 |
MESH:D000740 |
Anemia |
|
Fluorouracil |
8.13 | 16511603 17963324 15504547 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
8.13 | 11748828 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
3.88 | 19183758 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.28 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
7.24 | 15885639 |
MESH:D001169 |
Arthritis, Experimental |
|
Thalidomide |
7.24 | 9598899 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Ozone |
2.51 | 15570426 |
MESH:D001249 |
Asthma |
|
Ozone |
2.58 | 16373670 17854713 |
MESH:D050197 |
Atherosclerosis |
|
Methylcholanthrene |
3.34 | 11922910 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
8.19 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
8.19 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.60 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.64 | 15746008 |
MESH:D001943 |
Breast Neoplasms |
|
2,4-diaminotoluene |
6.82 | 11921183 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
6.82 | 17474063 20146248 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylnitrosamine |
6.82 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Fluorouracil |
6.82 | 15136595 16110121 19217205 16557594 18357371 16595493 18608205 |
MESH:D001943 |
Breast Neoplasms |
|
Genistein |
6.82 | 16873071 17200150 16541309 |
MESH:D001943 |
Breast Neoplasms |
|
Methylcholanthrene |
6.82 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Nickel |
6.82 | 15986119 |
MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
6.82 | 17261762 19288272 20065188 17440819 11161223 19487384 19200415 17893378 19155303 18815881 21152245 17049068 18425577 18855134 17242785 16202921 19066611 19221464 16818667 18629630 18821012 20859285 18984771 19011961 19289846 20390343 19244106 20544844 18997820 19115204 16273361 19142967 20135344 21138602 19059307 19084267 19103187 16873071 20005174 19410462 15565566 19189212 15668708 18351453 19189210 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
6.82 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachloroethylene |
6.82 | 15986119 |
MESH:D016535 |
Bronchial Hyperreactivity |
|
Ozone |
3.53 | 15516495 18315731 16777450 19059883 18417511 17626835 14754758 |
MESH:D002100 |
Cachexia |
|
Ozone |
4.55 | 16183385 |
MESH:D002276 |
Carcinoid Tumor |
|
Fluorouracil |
4.48 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Fluorouracil |
13.12 | 17121937 |
MESH:D002277 |
Carcinoma |
|
Methylcholanthrene |
13.12 | 10545420 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
13.12 | 16835633 |
MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
4.32 | 19066611 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Aflatoxin B1 |
16.39 | 12907637 12619106 21507988 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylnitrosamine |
16.39 | 17978847 20935162 18506893 16698587 19052882 18665156 16288022 20084675 19171122 20727157 20007298 19383236 19701751 18494052 17761372 18788625 16502159 16830150 16779866 20101231 18210153 16540662 18393292 10672840 19822196 16569478 21159647 20512989 19335982 20214788 17173139 19919837 3084413 17428255 19208518 18691550 3581430 18971187 17138121 20514400 16328049 10737359 19539802 18056438 11831363 19519916 18978308 20524982 16935385 16681979 16807293 18785209 20432363 17162532 16878318 19394651 19107877 19418558 17055752 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Fluorouracil |
16.39 | 17971768 18930000 17088986 16799960 17045692 16332177 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Genistein |
16.39 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Phenobarbital |
16.39 | 20007298 6705139 17173139 1701930 20935162 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
16.39 | 16507464 17306315 15276417 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
16.39 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Thalidomide |
16.39 | 16313753 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Fluorouracil |
2.93 | 18695887 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
10.36 | 20419170 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Fluorouracil |
10.36 | 18986760 16757204 17066447 16280240 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
10.36 | 18572023 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tetradecanoylphorbol Acetate |
10.36 | 18922899 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
3.45 | 17572228 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.26 | 18850075 18670907 16120746 |
MESH:D002318 |
Cardiovascular Diseases |
|
Genistein |
3.17 | 16332659 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
19.72 | 20889678 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
19.72 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Diethylnitrosamine |
19.72 | 7505956 17174075 2727394 21159647 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Methylcholanthrene |
19.72 | 16192471 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
19.72 | 20056578 19524636 |
MESH:D002493 |
Central Nervous System Diseases |
|
Phenobarbital |
4.06 | 4080065 |
MESH:D018281 |
Cholangiocarcinoma |
|
Diethylnitrosamine |
15.27 | 19052882 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
15.27 | 16835633 |
MESH:D018281 |
Cholangiocarcinoma |
|
Thalidomide |
15.27 | 18291259 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
12.53 | 19486331 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
12.53 | 16105132 11677210 17681005 17110522 16919318 17333356 15861022 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
12.53 | 19176532 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.03 | 12621046 16354765 15668235 15340226 8697196 |
MESH:D003092 |
Colitis |
|
Thalidomide |
4.66 | 16680017 |
MESH:D003110 |
Colonic Neoplasms |
|
Fluorouracil |
3.73 | 17016597 17018589 17172411 16340194 17725105 15001691 18772588 16510598 17287894 17169374 |
MESH:D003110 |
Colonic Neoplasms |
|
Genistein |
3.73 | 17182828 |
MESH:D015179 |
Colorectal Neoplasms |
|
Azacitidine |
2.82 | 19934284 |
MESH:D015179 |
Colorectal Neoplasms |
|
Fluorouracil |
2.82 | 15289873 18509181 17594712 14970324 17695437 18383874 18949393 16331619 18288408 15148649 17016601 20501625 17094418 16524972 18448328 17401013 16391804 17454858 18802399 16303861 16282729 17255274 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.90 | 17141729 14669216 |
MESH:D016510 |
Corneal Neovascularization |
|
Thalidomide |
5.38 | 9301478 |
MESH:D003389 |
Cranial Nerve Diseases |
|
Thalidomide |
6.11 | 9200351 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
2.81 | 20055451 15322242 10048152 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Thalidomide |
2.81 | 9200351 |
MESH:D003424 |
Crohn Disease |
|
Thalidomide |
4.07 | 16078585 |
MESH:D007644 |
Darier Disease |
|
Fluorouracil |
4.60 | 16733453 |
MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
4.17 | 19031437 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
Nickel |
3.77 | 17100760 19470301 17244072 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.34 | 18249437 |
MESH:D003877 |
Dermatitis, Contact |
|
Nickel |
4.46 | 2952479 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Diethylnitrosamine |
6.82 | 20387270 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Genistein |
6.82 | 16647724 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
6.82 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
3.32 | 19279558 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Diethylnitrosamine |
3.54 | 19107877 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
3.54 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.62 | 11462148 |
MESH:D004421 |
Dystonia |
|
Phenobarbital |
3.83 | 1851702 |
MESH:D004487 |
Edema |
|
pirinixic acid |
10.47 | 12083418 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
10.47 | 11000095 12711302 |
MESH:D004487 |
Edema |
|
Tetradecanoylphorbol Acetate |
10.47 | 7812673 16716910 8113982 8273558 11698051 15177302 9599246 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.71 | 18230668 15322242 16714409 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
8.33 | 12538720 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
8.33 | 19031437 |
MESH:D004714 |
Endometrial Hyperplasia |
|
Genistein |
4.40 | 16402032 |
MESH:D016889 |
Endometrial Neoplasms |
|
Genistein |
7.12 | 11473722 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
7.12 | 17893378 16202921 20544844 19155303 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
2.86 | 9294722 10568697 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Phenobarbital |
3.92 | 3659116 |
MESH:D004828 |
Epilepsies, Partial |
|
Phenobarbital |
3.68 | 11558140 3922381 |
MESH:D004827 |
Epilepsy |
|
Phenobarbital |
2.79 | 20417680 |
MESH:D004832 |
Epilepsy, Absence |
|
Phenobarbital |
3.38 | 6401628 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Phenobarbital |
4.06 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Phenobarbital |
3.83 | 3659116 |
MESH:D004931 |
Esophageal Achalasia |
|
Diethylnitrosamine |
4.92 | 16302075 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
6.93 | 20426865 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
6.93 | 16530937 |
MESH:D004938 |
Esophageal Neoplasms |
|
Fluorouracil |
6.93 | 16785472 16481741 17638652 16337965 15173087 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
2.87 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
22.79 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Diethylnitrosamine |
22.79 | 21071580 20387270 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
22.79 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
22.79 | 19236843 20131406 |
MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
22.79 | 14986274 19224547 |
MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
3.12 | 16709447 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.27 | 11858732 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
4.34 | 14745880 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
3.99 | 19069698 |
MESH:D005354 |
Fibrosarcoma |
|
Methylcholanthrene |
4.75 | 14633661 10962813 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
7.85 | 12639820 12168785 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
7.85 | 20067830 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
4.49 | 16452187 |
MESH:D005871 |
Giant Lymph Node Hyperplasia |
|
Thalidomide |
6.11 | 12701121 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.03 | 8708960 |
MESH:D005909 |
Glioblastoma |
|
Genistein |
3.14 | 16598420 |
MESH:D005910 |
Glioma |
|
Fluorouracil |
6.21 | 16145905 |
MESH:D005910 |
Glioma |
|
Thalidomide |
6.21 | 16327979 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.40 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Fluorouracil |
3.26 | 18337622 15102660 15162350 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
6.12 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
6.12 | 11294989 10048152 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.42 | 20558911 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.23 | 15720958 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.16 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
Phenobarbital |
13.29 | 16109766 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
13.29 | 18467677 16221962 19772884 19176532 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
13.29 | 12621046 15340226 16120746 |
MESH:D015658 |
HIV Infections |
|
Nickel |
3.72 | 17263646 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
3.00 | 12676792 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.85 | 16959395 15340226 16354765 8697196 18606429 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.02 | 20558911 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
4.70 | 10903974 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
4.70 | 18670907 18850075 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.62 | 16569931 16945680 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.28 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
6.22 | 17937319 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
6.22 | 15346721 12646999 |
MESH:D007249 |
Inflammation |
|
Diethylnitrosamine |
22.75 | 18785209 |
MESH:D007249 |
Inflammation |
|
Flavonoids |
22.75 | 17296493 |
MESH:D007249 |
Inflammation |
|
Nickel |
22.75 | 16166738 |
MESH:D007249 |
Inflammation |
|
Tamoxifen |
22.75 | 19457130 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
22.75 | 12200463 12878042 |
MESH:D007249 |
Inflammation |
|
Tetradecanoylphorbol Acetate |
22.75 | 15177302 11698051 7812673 7562506 8273558 |
MESH:D007249 |
Inflammation |
|
Thalidomide |
22.75 | 16134734 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
2.51 | 16306350 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.16 | 16580747 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.25 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
5.65 | 8314463 18776723 10903974 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
5.65 | 20008137 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
11.52 | 12371664 |
MESH:D007680 |
Kidney Neoplasms |
|
Fluorouracil |
11.52 | 16985049 |
MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
11.52 | 18625569 |
MESH:D007898 |
Leishmaniasis, Visceral |
|
Thalidomide |
4.20 | 16514283 |
MESH:D007938 |
Leukemia |
|
Azacitidine |
6.44 | 19148494 |
MESH:D007938 |
Leukemia |
|
Genistein |
6.44 | 17468513 18980019 |
MESH:D007951 |
Leukemia, Myeloid |
|
Azacitidine |
4.45 | 19077051 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Azacitidine |
4.50 | 18720364 17596541 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Thalidomide |
4.50 | 18720364 |
MESH:D054429 |
Leukemia, Myelomonocytic, Juvenile |
|
Azacitidine |
5.01 | 19299654 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Thalidomide |
4.32 | 10473037 |
MESH:D008064 |
Lipidoses |
|
Tamoxifen |
3.02 | 15342952 17567588 |
MESH:D008103 |
Liver Cirrhosis |
|
Diethylnitrosamine |
10.58 | 18665156 18407596 18522880 19638242 20032147 |
MESH:D008103 |
Liver Cirrhosis |
|
Phenobarbital |
10.58 | 21047994 |
MESH:D008103 |
Liver Cirrhosis |
|
Thalidomide |
10.58 | 17174718 16943688 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Genistein |
6.49 | 17823541 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
6.49 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
6.49 | 18564211 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
6.49 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Thalidomide |
6.49 | 15465738 |
MESH:D008107 |
Liver Diseases |
|
Diethylnitrosamine |
6.47 | 17034775 |
MESH:D008107 |
Liver Diseases |
|
Phenobarbital |
6.47 | 19363144 |
MESH:D008107 |
Liver Diseases |
|
Tetrachloroethylene |
6.47 | 17267091 |
MESH:D008113 |
Liver Neoplasms |
|
Aflatoxin B1 |
32.95 | 2125692 15890375 9163691 18177683 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
32.95 | 21137059 20195826 |
MESH:D008113 |
Liver Neoplasms |
|
beta-Naphthoflavone |
32.95 | 19389873 21295105 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylnitrosamine |
32.95 | 20452335 21167192 16942905 19642983 12771043 19255062 18754104 15885732 19254457 20501860 21047994 19833225 18644402 19996281 20137499 18978307 20101389 9163691 12112319 2422723 18648771 19850985 19812893 10737359 19426721 20492335 19690152 20583210 21278145 20118626 19499222 19090486 19427195 20405173 19638242 2862719 19073162 19551842 18977376 20434301 19294768 19256749 15175105 21071580 |
MESH:D008113 |
Liver Neoplasms |
|
Fluorouracil |
32.95 | 17045692 15113037 16603448 18383874 |
MESH:D008113 |
Liver Neoplasms |
|
Phenobarbital |
32.95 | 21047994 15975961 19812893 19073162 19482888 8742319 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
32.95 | 16377806 20007298 15890375 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
32.95 | 15276417 16712894 |
MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
32.95 | 16684651 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
32.95 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Aflatoxin B1 |
26.47 | 8603461 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
beta-Naphthoflavone |
26.47 | 18164116 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Diethylnitrosamine |
26.47 | 18308698 19126423 19004024 18775883 2563599 3124819 19519916 18079962 18164116 18544905 18253720 17854601 19009564 17174075 16267830 9362446 16842330 19539802 18093689 21159647 17942915 18282651 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Methylcholanthrene |
26.47 | 598648 1399818 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Phenobarbital |
26.47 | 18308698 17172636 6150874 1399818 2563599 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
26.47 | 12151625 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachloroethylene |
26.47 | 7955063 |
MESH:D008171 |
Lung Diseases |
|
Ozone |
7.09 | 19066396 8266340 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
7.09 | 19095001 |
MESH:D055370 |
Lung Injury |
|
Ozone |
3.66 | 20417186 |
MESH:D008175 |
Lung Neoplasms |
|
Aflatoxin B1 |
20.06 | 14755239 |
MESH:D008175 |
Lung Neoplasms |
|
Azacitidine |
20.06 | 21224363 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
20.06 | 18520028 20869020 17053015 20464547 6695378 20064080 18569708 18816296 20135361 |
MESH:D008175 |
Lung Neoplasms |
|
Diethylnitrosamine |
20.06 | 21163286 20512841 6695378 20970405 |
MESH:D008175 |
Lung Neoplasms |
|
Fluorouracil |
20.06 | 15246190 |
MESH:D008175 |
Lung Neoplasms |
|
Methylcholanthrene |
20.06 | 16271038 9230183 17909032 21163286 11893704 16337739 10545420 20970405 15390079 6695378 7750092 1399818 20512841 |
MESH:D008175 |
Lung Neoplasms |
|
Ozone |
20.06 | 7614698 8597069 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
20.06 | 17306315 15276417 17077188 19931552 16712894 |
MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
20.06 | 18625569 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
20.06 | 19555203 11884234 |
MESH:D008175 |
Lung Neoplasms |
|
Tetradecanoylphorbol Acetate |
20.06 | 11807781 |
MESH:D008178 |
Lupus Erythematosus, Cutaneous |
|
Fluorouracil |
4.60 | 15086387 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
3.57 | 19428831 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
2,4-diaminotoluene |
13.35 | 11921183 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Genistein |
13.35 | 12929590 14578162 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
13.35 | 19196722 11731420 19196723 14580682 16827153 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tetradecanoylphorbol Acetate |
13.35 | 8985016 |
MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
4.35 | 19453300 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
5.05 | 19082730 16487513 |
MESH:D008545 |
Melanoma |
|
Tamoxifen |
5.05 | 19393235 12393984 |
MESH:D008545 |
Melanoma |
|
Thalidomide |
5.05 | 12829675 16098027 17089043 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
3.99 | 15990972 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.59 | 16801185 |
MESH:D008679 |
Metaplasia |
|
Ozone |
4.91 | 10496685 |
MESH:D009006 |
Monosomy |
|
Azacitidine |
5.89 | 19299654 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
8.05 | 16381670 |
MESH:D009062 |
Mouth Neoplasms |
|
Fluorouracil |
8.05 | 16757204 18986760 |
MESH:D009101 |
Multiple Myeloma |
|
Azacitidine |
7.56 | 18443271 19549372 |
MESH:D009101 |
Multiple Myeloma |
|
Thalidomide |
7.56 | 15741222 15867202 15920492 19372569 16445831 19112817 19112201 17168659 15744524 15939924 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.32 | 16239165 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Azacitidine |
7.77 | 18720364 19805378 17596541 17611569 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Thalidomide |
7.77 | 18720364 |
MESH:D009203 |
Myocardial Infarction |
|
Genistein |
5.41 | 17141266 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
5.41 | 19151258 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
2.87 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Genistein |
7.91 | 17141266 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
7.91 | 16411023 |
MESH:D020191 |
Myoclonic Epilepsies, Progressive |
|
Phenobarbital |
4.28 | 17484760 |
MESH:D009362 |
Neoplasm Metastasis |
|
Diethylnitrosamine |
5.48 | 9029167 3581430 |
MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
5.48 | 19393235 |
MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.45 | 19410462 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
14.75 | 11141357 |
MESH:D009369 |
Neoplasms |
|
Fluorouracil |
14.75 | 16928823 18600527 18239605 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
14.75 | 17405874 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
14.75 | 11559025 |
MESH:D009369 |
Neoplasms |
|
Tetrachloroethylene |
14.75 | 11911487 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
3.48 | 20056578 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
3.81 | 19189210 19200415 19196722 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.25 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.12 | 19348381 18481113 |
MESH:D009421 |
Nervous System Malformations |
|
Genistein |
15.47 | 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
15.47 | 14600291 |
MESH:D009421 |
Nervous System Malformations |
|
Thalidomide |
15.47 | 16859833 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
3.02 | 12854658 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Diethylnitrosamine |
3.19 | 20387270 |
MESH:D009461 |
Neurologic Manifestations |
|
Diethylnitrosamine |
4.92 | 20387270 |
MESH:D020258 |
Neurotoxicity Syndromes |
|
Fluorouracil |
3.31 | 16436463 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.77 | 20558911 |
MESH:D010018 |
Osteomalacia |
|
Phenobarbital |
4.17 | 17016548 |
MESH:D010024 |
Osteoporosis |
|
Genistein |
3.14 | 19401787 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Genistein |
3.91 | 16169203 |
MESH:D010051 |
Ovarian Neoplasms |
|
Genistein |
7.73 | 19005980 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
7.73 | 15276417 17306315 |
MESH:D010051 |
Ovarian Neoplasms |
|
Thalidomide |
7.73 | 16288038 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Diethylnitrosamine |
11.80 | 16540662 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Fluorouracil |
11.80 | 19003803 16929163 16500647 15113037 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Phenobarbital |
11.80 | 16965848 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tetradecanoylphorbol Acetate |
11.80 | 15976015 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.51 | 11578682 |
MESH:D010212 |
Papilloma |
|
Tetradecanoylphorbol Acetate |
4.11 | 18404319 8330346 12065085 18922899 |
MESH:D010291 |
Paresis |
|
Thalidomide |
6.11 | 9200351 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.06 | 12520081 |
MESH:D010538 |
Peritonitis |
|
Ozone |
3.94 | 16369182 |
MESH:D011014 |
Pneumonia |
|
Ozone |
4.20 | 18929643 18007984 18381685 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.37 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
14.34 | 12371664 |
MESH:D011230 |
Precancerous Conditions |
|
Diethylnitrosamine |
14.34 | 2563599 |
MESH:D011230 |
Precancerous Conditions |
|
Phenobarbital |
14.34 | 2563599 |
MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
Thalidomide |
4.12 | 17031469 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.00 | 11118676 11399792 11222880 11896295 |
MESH:D011471 |
Prostatic Neoplasms |
|
Azacitidine |
2.08 | 18324645 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
2.08 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
Fluorouracil |
2.08 | 18626508 19082440 |
MESH:D011471 |
Prostatic Neoplasms |
|
Genistein |
2.08 | 15256057 15378649 16925846 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
2.08 | 16039940 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
2.08 | 15067354 |
MESH:D011471 |
Prostatic Neoplasms |
|
Thalidomide |
2.08 | 16729912 |
MESH:D011536 |
Prurigo |
|
Thalidomide |
6.11 | 12755975 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.12 | 16919318 15861022 |
MESH:D019310 |
Pseudolymphoma |
|
Phenobarbital |
4.30 | 12752131 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.16 | 16882103 |
MESH:D012004 |
Rectal Neoplasms |
|
Fluorouracil |
3.85 | 15538739 16160472 18286688 18722050 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.29 | 19058328 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.65 | 18990726 |
MESH:D019873 |
Schnitzler Syndrome |
|
Thalidomide |
5.75 | 16096327 |
MESH:D012640 |
Seizures |
|
Phenobarbital |
2.57 | 11442880 4039156 16876388 3137016 |
MESH:D003294 |
Seizures, Febrile |
|
Phenobarbital |
4.63 | 6407741 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
12.84 | 19755658 10029692 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
12.84 | 18572023 19524636 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
12.84 | 16192470 |
MESH:D012878 |
Skin Neoplasms |
|
Tetradecanoylphorbol Acetate |
12.84 | 8330346 12065085 18404319 8985016 11807781 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
10.92 | 16709447 |
MESH:D013088 |
Spermatocele |
|
Tamoxifen |
10.92 | 16709447 |
MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
3.85 | 19457130 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
3.65 | 12854658 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
3.25 | 20155912 2093021 |
MESH:D013274 |
Stomach Neoplasms |
|
Diethylnitrosamine |
3.25 | 18456281 |
MESH:D013274 |
Stomach Neoplasms |
|
Fluorouracil |
3.25 | 15786421 16424979 16951190 17522103 19084572 17498489 18567086 17172411 18396642 19015929 |
MESH:D013276 |
Stomach Ulcer |
|
Thalidomide |
4.00 | 15138204 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.44 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
2.99 | 15669648 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.71 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
Diethylnitrosamine |
6.70 | 7505956 |
MESH:D013964 |
Thyroid Neoplasms |
|
Phenobarbital |
6.70 | 1399818 |
MESH:D014062 |
Tongue Neoplasms |
|
Fluorouracil |
3.82 | 16280240 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
7.87 | 17053015 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
7.87 | 16452187 16712894 17306315 11723127 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
7.87 | 17572228 16712894 8653321 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Fluorouracil |
8.93 | 16803524 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
8.93 | 11813266 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
3.12 | 14692618 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
3.79 | 1336536 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
11.48 | 17056641 |
MESH:D014652 |
Vascular Diseases |
|
Thalidomide |
11.48 | 15741222 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.40 | 12125929 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.37 | 15869587 14671159 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.06 | 15886252 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.25 | 17120751 |